Your shopping cart is empty!
Ships within | Stock | Price | Qty | Total |
Please click "REQUEST A QUOTE" button if there is no stock, or you need other sizes or custom synthesis.
Catalog: | HY-W015967 |
Brand: | MCE |
CAS: | 79-14-1 |
MDL | MFCD00004312 |
---|---|
Molecular Weight | 76.05 |
Molecular Formula | C2H4O3 |
SMILES | O=C(O)CO |
Glycolic acid is an inhibitor of tyrosinase , suppressing melanin formation and lead to a lightening of skin colour.
Microbial Metabolite
|
Human Endogenous Metabolite
|
Different concentrations of Glycolic acid (GA) or LA (300 and 500 mg/mL) are tested on the growth of mouse and human melanoma cells. Both types of cells grow well, even in the presence of 300 mg/mL of each chemical for 5 days. However, 500 mg/mL Glycolic acid inhibits the cell growth of mouse melanoma cells (41%) and humanmelanoma cells (27%), and 500 mg/mL of LA inhibits the growth of mouse melanoma cells (36%) [1] .
MCE has not independently confirmed the accuracy of these methods. They are for reference only.
NCT Number | Sponsor | Condition | Start Date | Phase |
---|---|---|---|---|
NCT05362500 | Combined Military Hospital Abbottabad |
Melasma
|
June 1, 2021 | Phase 1 |
NCT01976286 | Northwestern University |
Melanosis
|
January 2015 | Not Applicable |
NCT05600075 | Zagazig University |
Acne Scars - Mixed Atrophic and Hypertrophic
|
November 1, 2022 | Not Applicable |
NCT02126657 | National University Hospital, Singapore |
Acne Scars
|
May 2014 | Phase 2 |
NCT01976273 | Northwestern University |
Melanosis
|
October 2013 | Not Applicable |
NCT03153852 | Assiut University |
Melasma
|
March 15, 2018 | Phase 4 |
NCT02126644 | National University Hospital, Singapore |
Photoaging
|
May 2014 | Phase 2 |
NCT05471947 | Main Line Center for Laser Surgery |
Photoaging|Lentigo
|
September 1, 2022 | Phase 4 |
NCT01289171 | University of Pennsylvania|NeoStrata Company, Inc.|Penn Center for AIDS Research (CFAR) |
Flat Warts (Diagnosis)|HIV Infections
|
January 2009 | Not Applicable |
NCT00472966 | Galderma R&D |
Melasma
|
November 2006 | Phase 4 |
NCT02812719 | Boston Medical Center |
Melasma
|
July 2018 | Early Phase 1 |
Solid
Room temperature in continental US; may vary elsewhere.
Powder | -20°C | 3 years |
---|---|---|
4°C | 2 years | |
In solvent | -80°C | 6 months |
-20°C | 1 month |
H 2 O : 100 mg/mL ( 1314.92 mM ; Need ultrasonic)
DMSO : ≥ 100 mg/mL ( 1314.92 mM )
* "≥" means soluble, but saturation unknown.
Concentration Solvent Mass | 1 mg | 5 mg | 10 mg |
---|
1 mM | 13.1492 mL | 65.7462 mL | 131.4924 mL |
5 mM | 2.6298 mL | 13.1492 mL | 26.2985 mL |
10 mM | 1.3149 mL | 6.5746 mL | 13.1492 mL |
Add each solvent one by one: PBS
Solubility: 100 mg/mL (1314.92 mM); Clear solution; Need ultrasonic
Add each solvent one by one: 10% DMSO >> 90% (20% SBE-β-CD in saline)
Solubility: ≥ 2.5 mg/mL (32.87 mM); Clear solution
Add each solvent one by one: 10% DMSO >> 90% corn oil
Solubility: ≥ 2.5 mg/mL (32.87 mM); Clear solution
Arctom is a premier supply platform offering over 600K unique items of Building Blocks, Bioactive Molecules, Natural Products, ADC PEG Linkers, Antibodies, and other Research Chemicals for global pharmaceutical, biotech, university, and industrial customers. We accelerate your research by providing better and faster purchasing experience & services.